Related Experiment Video

Updated: May 24, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Role of the JNK pathway in human diseases

Kanaga Sabapathy1

  • 1Division of Cellular & Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore.

Progress in Molecular Biology and Translational Science
|February 21, 2012
PubMed

Insights

The c-Jun-NH(2)-terminal kinase (JNK) pathway is crucial for cell fate and implicated in various diseases. Targeting JNK for therapy faces challenges due to specificity issues, but future directions aim to overcome these hurdles.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • The c-Jun-NH(2)-terminal kinase (JNK) signaling pathway is vital in regulating cell fate.
  • JNK pathway dysregulation is linked to numerous diseases, including cancer and inflammatory conditions.
  • Therapeutic inhibition of JNK shows promise in preclinical models, advancing to clinical trials.

Purpose of the Study:

  • To review the role of JNK signaling in human diseases.
  • To evaluate therapeutic strategies targeting JNK inhibition for disease amelioration.
  • To identify challenges and future directions for JNK pathway-targeted therapies.

Main Methods:

  • Literature review of JNK signaling in disease.
  • Analysis of therapeutic interventions targeting JNK.
  • Assessment of specificity challenges and potential solutions.

Main Results:

  • JNK pathway's broad involvement in diverse pathologies.
  • Evidence supporting JNK inhibition in ameliorating disease conditions.
  • Identification of lack of specificity as a key therapeutic challenge.

Conclusions:

  • The JNK pathway is a significant therapeutic target for various diseases.
  • Overcoming JNK pathway specificity issues is critical for effective treatment.
  • Further research into JNK-interacting proteins and substrates is needed for precise targeting.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...